Published in Arch Biochem Biophys on August 14, 2014
Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature (2010) 16.12
Melanoma biology and new targeted therapy. Nature (2007) 10.71
A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res (2005) 7.86
The cancer stem cell: premises, promises and challenges. Nat Med (2011) 6.73
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature (2010) 5.05
Treatment of metastatic melanoma: an overview. Oncology (Williston Park) (2009) 4.58
Dominant role of the niche in melanocyte stem-cell fate determination. Nature (2002) 4.05
KIT as a therapeutic target in metastatic melanoma. JAMA (2011) 3.49
Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci U S A (2005) 2.78
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol (2011) 2.38
Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature (2005) 2.37
Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res (2011) 2.08
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J Invest Dermatol (2011) 1.71
Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res (2008) 1.65
Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation. Pigment Cell Melanoma Res (2011) 1.61
Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res (2010) 1.50
The role of Kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res (2003) 1.44
Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer (2008) 1.43
Vitiligo puzzle: the pieces fall in place. Pigment Cell Res (2007) 1.39
Melanoma stem cells: the dark seed of melanoma. J Clin Oncol (2008) 1.37
Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res (2008) 1.35
Generation of human melanocytes from induced pluripotent stem cells. PLoS One (2011) 1.27
Update on the current state of melanoma incidence. Dermatol Clin (2012) 1.25
Review: melanocyte migration and survival controlled by SCF/c-kit expression. J Investig Dermatol Symp Proc (2001) 1.23
Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev (2002) 1.20
Dermis-derived stem cells: a source of epidermal melanocytes and melanoma? Pigment Cell Melanoma Res (2011) 1.14
Differential PAX3 functions in normal skin melanocytes and melanoma cells. Biochem Biophys Res Commun (2011) 1.12
Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Br J Pharmacol (1996) 0.95
Kit and melanocyte migration. J Invest Dermatol (2006) 0.94
Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation. J Invest Dermatol (2010) 0.93
Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? Lab Invest (2013) 0.92
Practical guidelines for the management of biochemotherapy-related toxicity in melanoma. Clin Cancer Res (2001) 0.88
Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin Dermatol (2013) 0.87
Vitiligo: new and emerging treatments. Dermatol Ther (2008) 0.86
Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. Br J Pharmacol (2012) 0.84
Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment. Melanoma Res (2011) 0.81
Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells. Neuropsychopharmacology (2009) 0.81
Small molecule modifier screen for kit-dependent functions in zebrafish embryonic melanocytes. Zebrafish (2008) 0.81
Extrafollicular dermal melanocyte stem cells and melanoma. Stem Cells Int (2012) 0.80
CD34 expression in desmoplastic melanoma. J Cutan Pathol (2001) 0.79
Does melanoma begin in a melanocyte stem cell? J Skin Cancer (2012) 0.79
CD34 expression in primary cutaneous malignant melanoma: apropos of a case and review of the aberrant melanoma phenotype. J Cutan Pathol (2005) 0.76
Effects of systemic 8-OH-DPAT on the feeding induced by hypothalamic NE infusion. Pharmacol Biochem Behav (1990) 0.76
Mechanistic studies of the transdermal iontophoretic delivery of 5-OH-DPAT in vitro. J Pharm Sci (2010) 0.76